MANCHESTER, England & MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Axalbion, a clinical-stage biopharmaceutical company focused on developing novel medicines to treat cough, today announced that the first ...
MANCHESTER, England & MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Axalbion, a clinical-stage biopharmaceutical company focused on developing novel medicines to treat cough, today announced positive ...
AX-8 reduces cough frequency and improves patient-reported outcomes in patients with chronic cough MANCHESTER, England & MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–June 29, 2022– Axalbion, a clinical-stage ...